Wells Fargo’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-26,000
Closed -$4.38M 7674
2023
Q1
$4.38M Buy
+26,000
New +$4.64M ﹤0.01% 2228

Other funds holding RGEN

Wells Fargo's RGEN Position: Q1 2026 in Review

Wells Fargo reduced its Repligen (RGEN) stake by 1.5% in Q1 2026, selling an estimated $78.8K and leaving 35,905 shares worth $4.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

Wells Fargo first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $258M in Q3 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Wells Fargo held 35,905 shares of Repligen worth $4.23M as of Q1 2026.
  • Wells Fargo sold 564 Repligen shares in Q1 2026, an estimated $78.8K.
  • Repligen made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2733 holding.
  • Wells Fargo first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Repligen position peaked at $258M in Q3 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.